Summary of Key Information:
Reporting Period (Quarter/Year): Quarter ended June 30, 2026 (Q1 FY27)
Nature of Filing / Announcement: Outcome of Board Meeting under Regulation 33 and Regulation 30 of SEBI Listing Regulations
Audit Opinion:
Limited Review Report with unmodified opinion issued by Statutory Auditors BSR & Co. LLP for both standalone and consolidated financial results.
Key Financial Highlights [₹ in crores]:
Standalone Results:
Revenue from Operations: ₹1,048.30 (Q1 FY27) vs ₹818.02 (Q1 FY26) - 28.2% YoY increase
Total Income: ₹1,089.17 (Q1 FY27) vs ₹852.54 (Q1 FY26)
Net Profit: ₹115.53 (Q1 FY27) vs ₹125.93 (Q1 FY26) - 8.3% YoY decrease
EPS: Basic ₹0.98, Diluted ₹0.98 (Face Value ₹2 each)
Other Equity: Not specified for quarter
Cash and Cash Equivalents: Not specified
Debt: Not specified
Consolidated Results:
Revenue from Operations: ₹3,090.63 (Q1 FY27) vs ₹2,237.63 (Q1 FY26) - 38.1% YoY increase
Total Income: ₹3,165.19 (Q1 FY27) vs ₹2,285.98 (Q1 FY26)
Net Profit: ₹243.43 (Q1 FY27) vs ₹254.04 (Q1 FY26) - 4.2% YoY decrease
Net Profit attributable to Owners: ₹231.65 (Q1 FY27)
Non-controlling interests: ₹11.78 (Q1 FY27)
EPS: Basic ₹1.96, Diluted ₹1.96 (Face Value ₹2 each)
Other Equity: ₹8,190.18 (as of March 31, 2026)
Cash and Cash Equivalents: Not specified
Debt: Not specified
Segment-wise Performance:
The Company operates in a single business and geographical segment (Healthcare services in India). For consolidated results, segment assets were ₹25,970.23 crore and segment liabilities were ₹16,915.03 crore as of June 30, 2026.
Corporate Actions:
- Appointment of M/s Price Waterhouse Chartered Accountants LLP as Statutory Auditors for 5 years from conclusion of 16th AGM (FY 2026-27) till conclusion of 21st AGM (2030-31), subject to shareholder approval
- Re-appointment of Dr. Hebri Sudarshan Ballal (DIN: 01195055) as Director, subject to shareholder approval at 16th AGM
- Re-appointment of Mr. Puneet Bhatia (DIN: 00143973) as Director, subject to shareholder approval at 16th AGM
- Amendment to Articles of Association to insert new Article 99.10 relating to right to nominate directors, subject to shareholder approval
- Convening of 16th Annual General Meeting on Tuesday, September 29, 2026 at 11:00 a.m. (IST) through Video Conferencing
Other Significant Information:
- Subsequent to quarter end, Company completed IPO of 157,233,715 equity shares of face value ₹2 each at issue price of ₹59.00 per share
- Shares listed on NSE and BSE on August 05, 2026
- Company acquired additional land measuring 752.77 sqm and building measuring 20,663.80 sqm for hospital expansion
- Subsequent to quarter end, Company entered into Business Transfer Agreement with Kindorama Healthcare Private Limited for acquisition of entire business operations of Kinder Women's Hospital, Bengaluru for cash consideration of ₹130.00 crore, subject to statutory approvals
- Exceptional items include discretionary one-time employee incentive of ₹13.43 crores (standalone) and ₹15.47 crores (consolidated) for quarter, and impact of Labour Codes implementation of ₹10.80 crores (standalone) and ₹31.94 crores (consolidated) for year ended March 31, 2026